コンテンツへスキップ
Merck
  • [N-dealkylation of chlorimipramine and chlorpromazine in patients undergoing chronic treatment with both drugs: preliminary results].

[N-dealkylation of chlorimipramine and chlorpromazine in patients undergoing chronic treatment with both drugs: preliminary results].

Bollettino della Societa italiana di biologia sperimentale (1984-09-30)
G P Sgaragli, R Ninci, L Della Corte, R Borghesi, M Nardini, N Battistini
要旨

Data obtained in this preliminary study show that in patients chronically treated either with Chlorimipramine (n = 6) or with Chlorpromazine (n = 2), significant amounts of the corresponding Nor1- and Nor2-metabolites were detected in plasma. The role of these metabolites in the overall therapeutic effect is under investigation.

材料
製品番号
ブランド
製品内容

Chlorpromazine impurity D, European Pharmacopoeia (EP) Reference Standard